CHORUS TETANUS IGG
MÉTODO INMUNOENZIMÁTICO PARA LA DETERMINACIÓN CUANTITATIVA DE ANTICUERPOS IGG ANTITOXINA TETÁNICA EN SUERO Y PLASMA HUMANO CON DISPOSITIVO DESECHABLE APLICADO A LOS EQUIPOS CHORUS Y CHORUS TRIO.
IMMUNOENZYMATIC METHOD FOR THE QUANTITATIVE DETERMINATION OF TETANUS ANTITOXIN IGG ANTIBODIES IN SERUM AND HUMAN PLASMA WITH DISPOSABLE DEVICE APPLIED TO CHORUS AND CHORUS TRIO EQUIPMENT.
- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- PARA LA DETERMINACIÓN CUANTITATIVA DE ANTICUERPOS IGG ANTITOXINA TETÁNICA
- Trade Name (English)
- FOR THE QUANTITATIVE DETERMINATION OF TETANUS TOXIN IGG ANTIBODIES
- Analysis ID
- 1035R2019 SSA
- Registration Date
- May 16, 2019
- Name (Spanish)
- GRIFOLS MÉXICO, S.A. DE C.V.
- Name (English)
- GRIFOLS MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for CHORUS TETANUS IGG (CHORUS TETANUS IGG) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1035R2019 SSA and manufactured by GRIFOLS MÉXICO, S.A. DE C.V.. The device was registered on May 16, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.